Get started
Author

Daniela Antenucci

Observed names: Antenucci Daniela, D. Antenucci, DANIELA ANTENUCCI
OpenAlex ID: A5075220401
Clinical and Hormonal Characteristics of Obese Amenorrheic Hyperandrogenic Women Before and After Weight Loss*
1989 · RENATO PASQUALI, DANIELA ANTENUCCI, et al. · The Journal of Clinical Endocrinology & Metabolism · 433
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
2017 · Olga Vaccaro, Maria Masulli, et al. · The Lancet Diabetes & Endocrinology · 295
Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study
2019 · Maria Chiara Rossi, Antonio Nicolucci, et al. · Nutrition Metabolism and Cardiovascular Diseases · 140
Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries
1986 · Renato Pasquali, Raffaella Fabbri, et al. · American Journal of Obstetrics and Gynecology · 93
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study
2016 · on behalf of the TOSCA.IT Study Group, M. Vitale, et al. · European Journal of Nutrition · 55
Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study
2016 · C.B. Giorda, M.C. Rossi, et al. · Nutrition Metabolism and Cardiovascular Diseases · 41
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)
2017 · G.P. Fadini, G. Zatti, et al. · Nutrition Metabolism and Cardiovascular Diseases · 30
Sex hormones in obese premenopausal women and their relationships to body fat mass and distribution, B cell function and diet composition
1987 · R. Pasquali, D. Antenucci, et al. · Journal of Endocrinological Investigation · 23
Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries
1987 · Renato Pasquali, D. Antenucci, et al. · Journal of Endocrinological Investigation · 17
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)
2022 · Gian Paolo Fadini, Raffaella Buzzetti, et al. · Acta Diabetologica · 6
PDF
Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins
2022 · Raffaella Buzzetti, Gian Paolo Fadini, et al. · Nutrition Metabolism and Cardiovascular Diseases · 6
PDF
Gender differences in type 2 diabetes (Italy)
2016 · Valeria Manicardi, Maria Chiara Rossi, et al. · Italian Journal of Gender-Specific Medicine · 3
Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
2008 · Mario Pupillo, Giorgia De Berardis, et al. · Diabetes Research and Clinical Practice · 3
La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale [Subcutaneous insulin infusion (CSII) in italy: The third national survey]
2015 · Daniela Bruttomesso, Luigi Laviola, et al. · IRIS UNIMORE (University of Modena and Reggio Emilia)
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale]
2015 · Daniela Bruttomesso, Luigi Laviola, et al.
Effect of Weight Loss and Antiandrogenic Therapy on Sex Hormone Blood Levels and Insulin Resistance in Obese Patients with Polycystic Ovaries
1986 · RENATO PASQUALI, RAFFAELLA FABBRI, et al. · Obstetrical & Gynecological Survey
Works count: 17
Citation count: 1,440
H-index: 10
I10-index: 10
Year
Topic
Type